Pfizer and CytoReason extend partnership for AI-driven drug discovery
Pfizer and CytoReason have expanded their collaboration to leverage the latter’s AI technology to develop the former’s drug programmes.
Stay updated with breaking news from Pharmaceutical Development Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pfizer and CytoReason have expanded their collaboration to leverage the latter’s AI technology to develop the former’s drug programmes.
Environmental and social exposures can majorly affect human health, and researchers are now finding ways to use that understanding in clinical research.
The Brazilian Health Regulatory Agency has granted emergency use authorization for Sinovac Biotech’s Covid-19 vaccine, CoronaVac, in kids.
A special purpose acquisition company (SPAC) focused on CDMOs has launched even as fundraising shell companies lose traction.
Switzerland’s pharma industry registered a 7.3% drops in IT hiring activity in February 2022, according to GlobalData